Beta-2 Microglobulin and Serum Cytokines x HAART

This study has been completed.

Sponsor:

UPECLIN HC FM Botucatu Unesp

ClinicalTrials.gov Identifier:

NCT00831207

First Posted: January 28, 2009

Last Update Posted: January 28, 2009

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

18 Years to 80 Years (Adult, Senior)

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Sampling Method:

Non-Probability Sample

Study Population

89 HIV-1-infected individuals assisted by the Tropical Diseases Sector of the Botucatu School of Medicine - UNESP and 20 normal blood donors at the Botucatu Blood Bank.

Criteria

Inclusion Criteria:

HIV-1-infected individuals

Over 18 years old

Sign the "written consent form" (WCF)

Exclusion Criteria:

Do not presenting other immunosuppression causes, such as neoplasias, transplantations

Do not presenting treatment by immunosuppressive substances

Do not presenting auto-immune diseases

Not be using any type of immunostimulating substances

Not at any time of gestation

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00831207